BMI KOREA
BMI KOREA engages in the production of pharmaceutical products and medical devices.
BMI KOREA
Industry:
Biotechnology Health Care Manufacturing Medical Device Pharmaceutical
Founded:
2005-09-05
Status:
Active
Contact:
82-64-724-5101
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Apache Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GlobalSign
Similar Organizations
Alfresa Holdings
Alfresa deals with wholesaling, manufacturing, import, and export of pharmaceutical products, diagnostic reagents, and medical devices.
Daikyo Seiko
Daikyo Seiko specialized in producing pharmaceutical packaging and medical device components.
Pharmaceutical and Medical Device Regulatory Science Society of Japan
PMRJ specializes in regulatory science related to drugs and medical devices.
Viscus Biologics
Viscus Biologics is a manufacture company that provides market innovative biologic products and Medical Device.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-04-28 | MetaFines | BMI KOREA investment in Series B - MetaFines | 20 B KRW |
| 2018-12-31 | MetaFines | BMI KOREA investment in Series A - MetaFines | 9 B KRW |
More informations about "BMI KOREA"
BMI KOREA | Leading Biopharmaceutical CDMO in South Korea
BMI KOREA is a leading Contract Development and Manufacturing Organization (CDMO) dedicated to advancing global healthcare through state-of-the-art biopharmaceutical โฆSee details»
BMIKorea - VentureRadar
BMI KOREA is a dynamically-growing pharmaceutical company, from First generic to First-in-class: First generic - Hyaluronidase (liquid), Polydeoxynucleotide; New drug - Combination โฆSee details»
About - BMI Korea
BMI KOREA LC. Tel: 070 8098 6040 Fax: 050 4492 1613. Email: [email protected]. Seoul Office: Seongwoo Starus #916, Yeoksam-ro 4-gil 16, Gangnam-gu, Seoul, Korea 06252 โฆSee details»
์กฐ์ง๋ | BMI์ฝ๋ฆฌ์ - bmik.co.kr
๋น์ ์์ด์ฝ๋ฆฌ์(BMI-KOREA) ๋ํ : ๋ฐฉ๋ณ๋ฌธ ์ฌ์ ์๋ฑ๋ก๋ฒํธ : 841-08-00090 Tel : 1600-5696 Fax : 032-232-4551 E-mail : [email protected] ๋ณธ์ฌ ๋ฐ ๊ณต์ฅ : ์์ธํน๋ณ์ ๊ฐ์๊ตฌ ์์ฒ๋ก โฆSee details»
BMI KOREA - Crunchbase Investor Profile & Investments
MetaFines raised โฉ20,000,000,000 / Series B from BMI KOREA and 8 other investors . Discover more funding rounds . View All . Details. Edit Details Section. Industries . Biotechnology . Health Care . Manufacturing . Medical Device . โฆSee details»
About us - BMI KOREA English site
Established BMI KOREA Co., Ltd. Acquired the GMP factory in Hyangnam Pharmaceutical Complex, Hwaseong; Global Business. BMI KOREA is set to rise as a global healthcare leader that contributes to the wholesome life of โฆSee details»
Home | BMI Korea
A customer-first approach, vast global experience and advanced trading techniques are what set BMI KOREA apart as an outstanding international business company. Based in Korea, we โฆSee details»
Our R&D center - BMI KOREA English site
BMI KOREA continues to build research infrastructure with continuous investment aimed at globalizing its R&D capabilities, to keep its capabilities focused on the development of products such as new drugs, biopharmaceutical drugs, and โฆSee details»
Greetings - BMI KOREA English site
BMI KOREA studies market demands and discovers and commercializes products for niche markets through rapid development, swift decision making, and speedy investment. Based on โฆSee details»
Solutions - BMI KOREA English site
BMI Korea provides integrated CDMO services, assisting pharmaceutical and biopharmaceutical companies develop and market their products successfully. As your qualified partner, BMI Korea ensures your success in IND, NDA, and โฆSee details»
Sites - ํ๊ตญ๋น์ ์์ด์ฝ๋ฆฌ์
BMI Korea recently built state-of-the-art facilities in Jeju and Osong to develop advanced biopharmaceuticals. We commit to deliver the highest quality biologics and medicines as your โฆSee details»
2020 Korean Society for the Study of Obesity Guidelines for the ...
The prevalence of obesity in Korea increased from 29.7% in 2010 to 35.7% in 2018, with the prevalence of abdominal obesity being 23.8% in 2018. ... The definition for obesity in adults is โฆSee details»
Body Mass Index and the Asian Community - ACE
9 hours ago Why BMI Falls Short for the AAPI Community. The commonly cited BMI categories used in research and clinical practice are as follows: a BMI of 30 kg/m 2 or greater equates to โฆSee details»
BMI classification of South Korea | Download Scientific Diagram
The patients were strati ed into two groups based on their BMI according to the Korean Society for the Study of Obesity and World Health Organization (WHO) de nitions of obesity for Asians โฆSee details»
What is the Average BMI in South Korea? | Body Mass Index
Dec 11, 2024 The Average BMI in South Korea. According to recent data, the average BMI for adults in South Korea is approximately 23.0 for men and 22.0 for women.This places the โฆSee details»
Effect of indoor air quality on potential risk of obstructive sleep ...
Apr 7, 2025 Using nationally representative data from the 2020โ2021 Korea National Health and Nutrition Examination Survey, we examined associations between indoor air pollutant โฆSee details»
2018 Korean Society for the Study of Obesity Guideline for the ...
WC is highly associated with intraabdominal fat.5 WC is measured in the horizontal plane midway between the superior iliac crest and the lower margin of the last rib.6 According to the KSSO, โฆSee details»
Whatโs in a Label: Obesity in One of the World's ... - KOREA EXPOSÉ
Mar 30, 2018 Despite years of debate within the medical community, BMI 30 has not demonstrated sufficient merit over BMI 25 in being the more accurate indicator of public health โฆSee details»
Obesity and Metabolic Syndrome in Korea - PMC
International Obesity Task Force (IOTF) and the World Health Organization (WHO) Regional Office for the Western Pacific Region recommend defining obesity in Asians as those with a โฆSee details»
Korean study finds โobeseโ BMI may actually be healthiest, urges ...
Nov 13, 2024 Currently, Korea follows the World Health Organisation Western Pacific Regionโs BMI standards that label a BMI of 18.5-22.9 as โnormalโ, 23-24.9 as โpre-obesity stageโ, or โฆSee details»